Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Celgene Corp (CELG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,906,408
  • Shares Outstanding, K 752,180
  • Annual Sales, $ 13,003 M
  • Annual Income, $ 2,940 M
  • 36-Month Beta 1.49
  • Price/Sales 5.18
  • Price/Cash Flow 11.76
  • Price/Book 10.19

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.25 +5.58%
on 04/03/18
91.97 -3.28%
on 04/18/18
+0.68 (+0.77%)
since 03/20/18
3-Month
84.25 +5.58%
on 04/03/18
106.67 -16.61%
on 01/26/18
-13.70 (-13.35%)
since 01/19/18
52-Week
84.25 +5.58%
on 04/03/18
147.17 -39.56%
on 10/02/17
-34.32 (-27.84%)
since 04/20/17

Most Recent Stories

More News
CELGENE SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Celgene Corporation - CELG

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 29, 2018 to file lead plaintiff applications...

CELG : 88.95 (-0.75%)
CELGZ : 0.25 (+19.05%)
EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Celgene Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 - CELG

The following statement is being issued by Levi & Korsinsky, LLP:

CELG : 88.95 (-0.75%)
CELGZ : 0.25 (+19.05%)
Novartis (NVS) Reports Encouraging Data on MS Candidate

Novartis (NVS) announces encouraging results from a phase III study, EXPAND, on siponimod (BAF312) in patients with secondary progressive multiple sclerosis.

CELG : 88.95 (-0.75%)
NVS : 77.88 (-1.42%)
TEVA : 17.82 (+0.62%)
BIIB : 263.02 (-1.13%)
Amgen (AMGN) to Report Q1 Earnings: Is a Beat in the Cards?

While Amgen's (AMGN) growth drugs like Prolia & Xgeva might do well, biosimilar competition and slowdown in sales of mature products can put pressure on sales growth.

CELG : 88.95 (-0.75%)
AGN : 158.51 (-0.05%)
AMGN : 171.56 (-0.79%)
ALXN : 107.78 (-3.54%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Celgene Corporation (CELG) and Lead Plaintiff Deadline: May 29, 2018

NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed Celgene Corporation (''Celgene'' or the ''Company'') (NASDAQ:...

CELG : 88.95 (-0.75%)
CELGZ : 0.25 (+19.05%)
Top Research Reports for IBM, McDonald's & Gilead

Top Research Reports for IBM, McDonald's & Gilead

CELG : 88.95 (-0.75%)
PSX : 110.99 (+0.32%)
IBM : 144.90 (-1.90%)
LRCX : 191.91 (+0.80%)
GILD : 73.70 (-0.99%)
MCD : 158.77 (-0.48%)
Celgene Corporation Announces Changes to Its Board of Directors

--US health insurance expert Patricia Hemingway Hall elected to Board of Directors

CELG : 88.95 (-0.75%)
CELGZ : 0.25 (+19.05%)
JUNO : 86.96 (+0.10%)
Agios' Leukemia Drug Bodes Well for Growth & Strong Pipeline

The FDA approval for Agios' (AGIO) only marketed drug, Idhifa, augurs well for long-term growth. The company is also well on progress track with its lead candidate, ivosidenib, for R/R AML.

AGIO : 86.45 (-2.08%)
CELG : 88.95 (-0.75%)
LGND : 166.98 (-0.96%)
INFI : 2.24 (+1.82%)
Celgene Corporation to Webcast at Upcoming Investor Conferences

Celgene Corporation (NASDAQ: CELG) plans to present at three upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast...

CELG : 88.95 (-0.75%)
CELGZ : 0.25 (+19.05%)
DB : 14.26 (-1.38%)
CELGENE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Celgene Corporation - CELG

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 29, 2018 to file lead plaintiff applications in a securities class action lawsuit against Celgene Corporation...

CELG : 88.95 (-0.75%)
CELGZ : 0.25 (+19.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID,...

See More

Key Turning Points

2nd Resistance Point 90.99
1st Resistance Point 89.97
Last Price 88.95
1st Support Level 88.09
2nd Support Level 87.23

See More

52-Week High 147.17
Fibonacci 61.8% 123.13
Fibonacci 50% 115.71
Fibonacci 38.2% 108.29
Last Price 88.95
52-Week Low 84.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar